Dallas, TX · Founded 2014 · Privately Held (backing)
Developer of a nanotechnology platform designed to improve the delivery and activation of cancer therapies in acidic tumor environments. OncoNano Medicine is based in Dallas, TX and was founded in 2014. It was valued at $60 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $117 million across 3 recorded rounds; the latest was a $12.7 million early-stage round in Apr 2025.
PMV mark · valuation
$60.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$116.5M
Last round
Early Stage VC
Apr 2025
Team — not yet on record
No current team members for OncoNano Medicine are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of OncoNano Medicine with a free account
·Watch OncoNano Medicine: the Monday email on marks, rounds and moves
